KEAP1 and non-small cell lung carcinoma: Clobetasol propionate, a synthetic glucocorticoid, was used by Choi et al. to suppress the in vitro and in vivo growth of Kelch-like ECH-associated protein 1 (KEAP1) mutant NSCLC.